Treatment | Cost ($) | LYs | QALYs | ICER ($/LY) | ICER ($/QALY) |
Lap+Cap | 54 399.1 | 2.136 | 1.569 | ||
Ner+Cap | 58 698.3 | 2.567 | 1.908 | 9970.1 | 12 670.2 |
Cap, capecitabine; ICER, incremental cost-effectiveness ratio; Lap, lapatinib; LY, life-year; Ner, Neratinib; QALY, quality-adjusted life year.